Gerald Johnston

Biblical Chronology Deciphered is a unique result of applying a scientific approach to biblical records to produce an exact biblical chronology. The Bible's known time data are gathered and arranged to reveal only two pieces are missing, and one of these is available from two separate archaeological sources. With the assumption that the graciously preserved and well-accepted artifacts are valid, the only remaining piece of the puzzle is hypothesized and numerically evaluated to reveal the Bible's claim: the mathematically defensible, biblical year of creation. The associated correlations from the finished result, plus solutions to ancient mysteries are astounding. You will learn the identity of the man who touched Elisha's bones and resurrected, the exact day and year of Jesus Christ's birth, the likely solution to the 666 puzzle in the book of Revelation, many patterns designed into time, answers to questions of atheists, and more. This professionally researched work contains many insights including translation anomalies and their resolutions. The book, written to both the lay reader and the scholar, will boost your faith while enlarging your understanding of the Bible. THIS IS THE ONLY ACCURATE TO-THE-YEAR BIBLICAL CHRONOLOGY IN HUMAN HISTORY The author asserts that while it is impossible for any scientific method to definitively determine the age of Earth, it is scientifically possible to determine the Bible's claimed-age and produce a precise biblical chronology.

In 1970, under the sponsorship of Oak Ridge Associated Univer­ sities (ORAU), a group of clinical investigators formed the Cooper­ ative Group to Study Localization of Radiopharmaceuticals. The first radiopharmaceutical selected for study was 67-Gallium (67-Ga) administered as the citrate. The object of the study was to de­ termine the usefulness of 67-Ga in the diagnosis and treatment of patients with various malignancies. Funding for the project was granted by the U. S. Atomic Energy Commission and the National Cancer Institute, National Institutes of Health (NIH). The Nuclear Medicine Department of the Clinical Center, NIH, agreed to assist ORAU with aspects of this study, particularly with 67-Ga scin­ tigraphy of patients with lymphoma and Hodgkin's disease. Pre­ liminary reports from the ORAU study are in press. Since April 1971, 67-Ga scintigraphy has gained increasing use in the study of cancer patients at the Clinical Center, NIH, where well over 1000 such patients have been examined by this method. This monograph was written to present selected examples from this group of a variety of malignancies seen in this 28-month period. No attempt has been made to correlate this overall experience statistically. Rather, this presentation is to help familiarize the practitioner of Nuclear Medicine with the wide range of usefulness for 67-Ga scintigraphy while making him aware of the variation in scan appearance and watchful of the many pitfalls of 67-Ga scan interpretation. Permission to use these patient studies and x-rays was generously granted by Dr. Paul P.